675
Views
7
CrossRef citations to date
0
Altmetric
Correspondence

Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin‐based regimen

, &
Pages 454-457 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dolors Rodríguez-Pardo, Carles Pigrau, Pablo S Corona & Benito Almirante. (2015) An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future. Expert Review of Anti-infective Therapy 13:2, pages 249-265.
Read now

Articles from other publishers (6)

Umile Giuseppe Longo, Sergio De Salvatore, Benedetta Bandini, Alberto Lalli, Bruno Barillà, Nicolaas Cyrillus Budhiparama & Sebastien Lustig. (2023) Debridement, antibiotics, and implant retention (DAIR) for the early prosthetic joint infection of total knee and hip arthroplasties: a systematic review. Journal of ISAKOS.
Crossref
Lei Wang, Tamta Tkhilaishvili, Andrej Trampuz & Mercedes Gonzalez Moreno. (2020) Evaluation of Staphylococcal Bacteriophage Sb-1 as an Adjunctive Agent to Antibiotics Against Rifampin-Resistant Staphylococcus aureus Biofilms. Frontiers in Microbiology 11.
Crossref
Stefan Nißen, Jan Heeg, Marion Wienecke, Detlef Behrend, Mareike Warkentin, Krzysztof Rokosz, Sofia Gaiaschi & Patrick Chapon. (2019) Surface Characterization and Copper Release of a-C:H:Cu Coatings for Medical Applications. Coatings 9:2, pages 119.
Crossref
Martin McNally & Parham Sendi. 2015. Bone and Joint Infections. Bone and Joint Infections 303 323 .
Hee Dong LeeKumar PrashantWon Yong Shon. (2015) Management of Periprosthetic Hip Joint Infection. Hip & Pelvis 27:2, pages 63.
Crossref
Laurence Legout, Piervito Delia, Béatrice Sarraz-Bournet, Cécile Rouyer, Massongo Massongo, Michel Valette, Olivier Leroy, Stephan Haulon & Eric Senneville. (2014) Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin. BMC Infectious Diseases 14:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.